Browse > Article

Toxicogenomic Analysis and Identification of Estrogen Responsive Genes of Di (n-ethylhexyl) Phthalate in MCF-7 Cells  

Kim, Youn-Jung (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology)
Yun, Hye-Jung (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology)
Ryu, Jae-Chun (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology)
Publication Information
Molecular & Cellular Toxicology / v.1, no.3, 2005 , pp. 149-156 More about this Journal
Abstract
Di (n-ethylhexyl) phthalate (DEHP) is thought to mimic estrogens in their action, and are called endocrine disrupting chemicals. DEHP is used in numerous consumer products, especially those made of flexible polyvinyl chloride and have been reported to be weakly estrogenic. In this study, DEHP were tested for estrogenic properties in vitro models and with microarray analysis. First, the E-screen assay was used to measure the proliferation of DEHP in MCF-7 cells, a human breast cancer cell line. DEHP induced an increase in MCF-7 cell proliferation at concentration of $10^{-4}M$. Second, we carried out a microarray analysis of MCF-7 cells treated with DEHP using human c-DNA microarray including 401 endocrine system related genes. Of the genes analyzed, 60 genes were identified showing significant changes in gene expression resulting from DEHP. Especially, 4 genes were repressed and 4 genes were induced by DEHP compared to $17{\beta}-estradiol$. Among these genes, trefoil factor 3 (intestinal), breast cancer 1, early onset and CYP1B1 are involved in estrogen metabolism and regulation. Therefore it suggests that these genes may be associated with estrogenic effect of the DEHP on transcriptional level. The rationale is that, as gene expression is a sensitive endpoint, alterations of these genes may act as useful biomarkers to define more precisely the nature and level of exposure to kinds of phthalates.
Keywords
di (n-ethylhexyl) phthalate (DEHP); gene expression; biomarker; estrogen responsive gene; endocrine disrupting chemicals;
Citations & Related Records

Times Cited By Web Of Science : 4  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Danzo, B.J. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ. Health Perspect. 105, 294-301 (1997)   DOI   ScienceOn
2 CERHR. NTP-CERHR Expert Panel Report on Di (2- ethylhexyl) Phthalate, http://cerhr.niehs.nih.gov/ news/phthalates/DEHP-final.pdf.U.S. Department of Health and Human Services, National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction, Research Triangle Park, NC (2000)
3 Kluwe, W.M. et al. Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ. Health Perspect. 45, 129-133 (1982)   DOI
4 Harris, C.A., Henttu, P., Parker, M.G. & Sumpter, J.P. The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect. 105, 802-811 (1997).   DOI   ScienceOn
5 Nielsen, M., Hoyer, P.E., Lemmen, J.G., van der Burg, B. & Byskov, A.G. Octylphenol does not mimic diethylstilbestrol-induced oestrogen receptoralpha expression in the newborn mouse uterine epithelium after prenatal exposure. J. Endocrinol. 167, 29-37 (2000)   DOI
6 Inoue, T. Toxicogenomics- a new paradigm of toxicology. In: Toxicogenomics (Inoue, T., Pennie, W. D., eds). Tokyo: Springer, 3-11 (2003)
7 Ryu, J.C. & Kim, Y.J. Construction and validation of human cDNA microarray for estimation of endocrine disrupting chemicals (KISTCHIP-400 ver.1.0). Mol. Cell. Toxicol. 1, 52-61 (2005)
8 Crespi, C.L. et al. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens. Mutagenesis 12, 83-89 (1997)   DOI   ScienceOn
9 Imanishi, S. et al. Effects of oral exposure of bisphenol A on mRNA expression of nuclear receptors in murine placentae assessed by DNA microarray. J. Reprod. Dev. 49, 329-336 (2003).   DOI   ScienceOn
10 Marks, J.R. et al. BRCA1 expression is not directly responsive to estrogen. Oncogene 14, 115-121 (1997)   DOI   ScienceOn
11 King, M.C., Marks, J.H. & Mandell, J.B. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643-646 (2003)   DOI   ScienceOn
12 Poon, R. et al. Subchronic oral toxicity of di-n-octyl phthalate and di (2-Ethylhexyl) phthalate in the rat. Food Chem. Toxicol. 35, 225-239 (1997)   DOI   ScienceOn
13 Tusher, V., Tribshirani, R. & Chu, C. Significance analysis of microarrays applied to ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001)   DOI   ScienceOn
14 Asai, D. et al. Structural essentials of xenoestrogen dialkyl phthalates to bind to the estrogen receptors. Toxicol. Lett. 118, 1-8 (2000)   DOI
15 Sole, R.V., Bonabeau, E., Delgado, J., Fernandez, P. & Marin, J. Pattern formation and optimization in army ant raids. Artificial Life 6, 219-226 (2000)   DOI   ScienceOn
16 Blass, C.R. PVC as a biomedical polymer-plasticizer and stabilizer toxicity. Med. Device Technol. 3, 32-40 (1992)
17 Smeds, A. & Saukko, P. Identification and quantification of polychlorinated bisphenols and some endocrine disrupting pesticides in human adipose tissue from Finland. Chemosphere 44, 1463-1471 (2001)   DOI   ScienceOn
18 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. http://www.institutodopvc.org/ english/monografia.html March (2003)
19 Shimada, T. et al. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab. Dispos. 25, 617-622 (1997)
20 Lovekamp-Swan, T. & Davis, B.J. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ. Health Perspect. 111(2), 139-145 (2003)   DOI   ScienceOn
21 Faouzi, M.A. et al. Exposure of hemodialysis patients to di-2-ethylhexyl phthalate. Int. J. Pharm. 180, 113- 121 (1999)   DOI   ScienceOn
22 Paganetto, G. et al. Endocrine-disrupting agents on healthy human tissues. Pharmacol. Toxicol. 86, 24-29 (2000)
23 Huang, C.H. & Sedlak, D.L. Analysis of estrogenic hormones in municipal wastewater effluent and surface water using ELISA and GC/MS/MS. Environ. Toxicol. Chem. 20, 133-139 (2001)   DOI   ScienceOn
24 Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63 (1983)   DOI
25 Jobling, M.A., Bouzekri, N. & Taylor, P.G. Hypervariable digital DNA codes for human paternal lineages: MVR-PCR at the Y-specific minisatellite, MSY1 (DYF155S1). Human Mol. Genet. 7, 643-653 (1998)   DOI
26 Ryu, J.C., Kim, M.K., Choi, M.H. & Chun, T.H. Promising next generation technology in toxicologytoxicogenomics. Mol. Cell. Toxicol. 1, 1-6 (2005)
27 Soto, A.M. et al. The E-SCREEN assay as a tool to identify estrogens : An update on estrogenic environmental pollutants. Environ. Health Perspect. 103, 113-122 (1995)   DOI
28 Gaido, K.W. et al. Evaluation of chemicals with endocrine modulating activity in a Yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205-212 (1997)   DOI   ScienceOn
29 Spink, D.C. et al. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19, 291-298 (1998)   DOI
30 Huber, W.W., Grasl-Kraupp, B. & Schulte-Hermann, R. Hepatocarcinogenic potential of di (2-ethyl hexyl) phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26, 365-481 (1996).   DOI   ScienceOn
31 Ward, J.M., Rice, J.M., Creasia, D., Lynch, P. & Riggs, C. Dissimilar patterns of promotion by di (2- ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 4, 1021-1029 (1983)   DOI   ScienceOn
32 Blom, A., Ekman, E., Johannisson, A., Norrgren, L. & Pesonen, M. Effects of xenoestrogenic environmental pollutants on the proliferation of a human breast cancer cell line (MCF-7). Arch. Environ. Contam. Toxicol. 34, 306-310 (1998)   DOI   ScienceOn
33 Takeyoshi, M. et al. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions. Toxicol. Lett. 126, 91-98 (2002)   DOI   ScienceOn
34 NTP. Di (2-ethylhexyl) phthalate (CAS No. 117-81- 7). In: Report on Carcinogens, 8th ed, Summary 1998. Research Triangle Park, NC: National Toxicology Program.100-102 (1998)
35 Diwan, B.A., Ward, J.M., Rice, J.M., Colburn, N.H. & Spangler, E.F. Tumor-promoting effects of di (2- ethylhexyl)phthalate in JB6 mouse epidermal cells and mouse skin. Carcinogenesis 6, 343-347 (1985)   DOI   ScienceOn
36 Terasaka, S. et al. Using a customized DNA microarray for expression profiling of the estrogenresponsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ. Health Perspect 112, 773-781 (2004)   DOI   ScienceOn
37 Faith DA. et al. Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays. Prostate 61(3), 215-227 (2004)   DOI   ScienceOn
38 Skakkebaek, N.E. Endocrine disrupters and testicular dysgenesis syndrome. Horm. Res. 57, 43 (2002)   DOI
39 Coumoul, X., Diry, M., Robillot, C. & Barouki, R. Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res. 61, 3942- 3948 (2001)
40 Nilsen, B.M. et al. Development of quantitative vitellogenin- ELISAs for fish test species used in endocrine disruptor screening. Anal. Bioanal. Chem. 378, 621- 633 (2004)   DOI   ScienceOn
41 Davis, B.J., Maronpot, R.R. & Heindel, J.J. Di-(2- ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol. Appl. Pharmacol. 128(2), 216-223 (1994).   DOI   ScienceOn
42 Doull, J. et al. A cancer risk assessment of di (2- ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Regul. Toxicol. Pharmacol. 29, 327-357 (1999)   DOI   ScienceOn